In this study, we examined the expression levels of KLB in tumor vs. non-tumor tissues of NSCLC, explored its clinical relevance as a diagnostic/prognostic biomarker, and tested its antitumor effect both in vitro and in vivo. This evidence concerns the gene KLB and neoplasm.